Sustained Virologic Response for Chronic Hepatitis C Infection after 27 Days of Treatment with Sofosbuvir and Ribavirin.
about
Subgroup differences in response to 8 weeks of ledipasvir/sofosbuvir for chronic hepatitis CPrevalence of end of treatment RNA-positive/sustained viral response in HCV patients treated with sofosbuvir combination therapiesModeling HCV cure after an ultra-short duration of therapy with direct acting agents.Resurrection of response-guided therapy for sofosbuvir combination therapies.Continued value in understanding viral kinetic decline during interferon-free therapy for HCV.Hepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: Case report.
P2860
Sustained Virologic Response for Chronic Hepatitis C Infection after 27 Days of Treatment with Sofosbuvir and Ribavirin.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Sustained Virologic Response f ...... with Sofosbuvir and Ribavirin.
@ast
Sustained Virologic Response f ...... with Sofosbuvir and Ribavirin.
@en
Sustained Virologic Response f ...... with Sofosbuvir and Ribavirin.
@nl
type
label
Sustained Virologic Response f ...... with Sofosbuvir and Ribavirin.
@ast
Sustained Virologic Response f ...... with Sofosbuvir and Ribavirin.
@en
Sustained Virologic Response f ...... with Sofosbuvir and Ribavirin.
@nl
prefLabel
Sustained Virologic Response f ...... with Sofosbuvir and Ribavirin.
@ast
Sustained Virologic Response f ...... with Sofosbuvir and Ribavirin.
@en
Sustained Virologic Response f ...... with Sofosbuvir and Ribavirin.
@nl
P2093
P2860
P356
P1476
Sustained Virologic Response f ...... with Sofosbuvir and Ribavirin
@en
P2093
Anu Osinusi
Eric G Meissner
Henry Masur
Miriam Marti
P2860
P356
10.1093/OFID/OFU013
P577
2014-01-01T00:00:00Z